2,327
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Ambulatory blood pressure monitoring in treated patients with hypertension in the COVID-19 pandemic - The study of European society of hypertension (ESH ABPM COVID-19 study)

, , , , , , , , ORCID Icon & show all
Article: 2161998 | Received 17 Nov 2022, Accepted 18 Dec 2022, Published online: 24 Jan 2023

References

  • Kreutz R, Dobrowolski P, Prejbisz A, European Society of Hypertension COVID-19 Task Force Review, et al. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021;39(6):1077–1089.
  • Pecanha T, Goessler KF, Roschel H, et al. Social isolation during the covid-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2020;318(6):H1441–H1446.
  • Januszewicz A, Wojciechowska W, Prejbisz A, et al. Impact of the COVID-19 pandemic on blood pressure control and cardiovascular risk profile in patients with hypertension. Pol Arch Intern Med. 2021;131:16129.
  • Williams B, Mancia G, Spiering W, ESC Scientific Document Group, et al. ESC scientific document group. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
  • Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.
  • Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260.
  • Williams B. Renin-angiotensin system inhibitors in hospitalised patients with COVID-19. Lancet Respir Med. 2021;9(3):221–222.
  • Kreutz R, Algharably EAE, Azizi M, et al. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for covid-19. Cardiovasc Res. 2020;116(10):1688–1699.
  • The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the european society of hypertension. J Hypertens. 2021;39:190–195.
  • Pengo MF, Albini F, Guglielmi G, et al. Home blood pressure during covid-19-related lockdown in patients with hypertension. Eur J Prev Cardiol. 2022;29(3):e94–e96.
  • Laffin LJ, Kaufman HW, Chen Z, et al. Rise in blood pressure observed Among US adults During the COVID-19 pandemic. Circulation. 2022;145(3):235–237.
  • Gotanda H, Liyanage-Don N, Moran AE, et al. Changes in blood pressure outcomes Among hypertensive individuals During the COVID-19 pandemic: a time series analysis in three US healthcare organizations. Hypertension. 2022;79(12):2733–2742.
  • Feitosa FGAM, Feitosa ADM, Paiva AMG, et al. Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study. Hypertens Res. 2022;45(2):364–368.
  • Omboni S, Ballatore T, Rizzi F, et al. Telehealth at scale can improve chronic disease management in the community during a pandemic: an experience at the time of COVID-19. PLoS One. 2021;16(9):e0258015.
  • Stergiou GS, Palatini P, Parati G, European Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability, et al. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–1302.
  • Hoshide S, Kario K. Morning surge in blood pressure and stroke events in a large modern ambulatory blood pressure monitoring cohort: results of the JAMP study. Hypertension. 2021; Sep 78(3):894–896.
  • Mena L, Pintos S, Queipo NV, et al. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–511.
  • Bilo G, Giglio A, Styczkiewicz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens. 2007;25(10):2058–2066.
  • Pina A, Castelletti S. COVID-19 and cardiovascular disease: a global perspective. Curr Cardiol Rep. 2021;23(10):135.
  • The task force for the management of COVID-19 of the european society of cardiology, ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up. Europ Heart J. 2022;43(11):1059–1103.
  • Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020;16(1):57.
  • The Lancet Gastroenterology Hepatology Drinking alone: COVID-19, lockdown, and alcohol-related harm. Lancet Gastroenterol Hepatol. 2020;5(7):625.
  • van Zyl-Smit RN, Richards G, Leone FT. Tobacco smoking and COVID-19 infection. Lancet Respir Med. 2020;8(7):664–665.
  • Weber T, Amar J, de Backer T, Covid-19 Task Force of the European Society of Hypertension, et al. Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in excellence centers of the european society of hypertension. Blood Press. 2022;31(1):71–79.
  • Girerd N, Meune C, Duarte K, et al. Evidence of a blood pressure reduction During the COVID-19 pandemic and associated lockdown period: insights from e-Health data. Telemed J E Health. 2022;28(2):266–270.
  • Burnier M, Kjeldsen SE, Narkiewicz K, et al. Hypertension management during the COVID-19 pandemic: what can we learn for the future? Blood Press. 2022;31(1):47–49.
  • Banerjee A, Chen S, Pasea L, et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. 2021;28(14):1599–1609.